Redhill Biopharma
RDHL
#11135
Rank
C$4.81 M
Marketcap
C$0.54
Share price
-6.91%
Change (1 day)
-69.55%
Change (1 year)

Redhill Biopharma (RDHL) - Net assets

Net assets on the balance sheet as of December 2025 : C$5.96 Million

According to Redhill Biopharma's latest financial reports the company has C$5.96 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Redhill Biopharma - Net assets on balance sheet (from 2011 to 2025)

Net assets by year

Year Net assets Change
2025-12-31$C$5.84 M-186.98%
2024-12-31$-C$6.73 Million-344.88%
2023-12-31$C$2.74 M-104.18%
2022-12-31$-C$65.68 Million-680.66%
2021-12-31$C$11.31 M-36.02%
2020-12-31$C$17.67 M-77.44%
2019-12-31$C$78.36 M12.39%
2018-12-31$C$69.72 M23.06%
2017-12-31$C$56.65 M-32.76%
2016-12-31$C$84.26 M1.11%
2015-12-31$C$83.33 M187.13%
2014-12-31$C$29.02 M128.65%
2013-12-31$C$12.69 M-32.88%
2012-12-31$C$18.91 M-1.04%
2011-12-31$C$19.11 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Sanofi
SNY
C$110.94 B 1,860,232.71%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$58.66 B 983,592.60%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$31.80 B 533,184.91%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$10.83 B 181,647.89%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
C$2.48 B 41,584.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel